FemiCore vs Uqora: Which One Has the Evidence for UTIs?

Published on October 7, 2026 — by Ellen Bennett, Women’s Health Researcher

Medical & Affiliate Disclosure: This article is for educational purposes only and is not medical advice. Always talk to your doctor about urinary symptoms and before starting any supplement, especially if you take prescription medication. We are not affiliated with Uqora and earn nothing if you buy it. Some links below are affiliate links for FemiCore; if you buy through them we may earn a commission at no extra cost to you. That does not change what we write.

Independent women’s health research · Written and fact-checked by Ellen Bennett, Women’s Health Researcher · Last verified: October 2026

If you have had more UTIs than you can count, you have almost certainly seen Uqora. It is the pink-and-white brand all over Instagram, with a drink mix you stir into water after sex and tens of thousands of five-star reviews. FemiCore is the quieter one: a single daily capsule sold from one website. So FemiCore vs Uqora sounds like a contest between a famous brand and an underdog.

It is not really that. Uqora is a line of seven or eight products, and each one rests on a different ingredient with a very different amount of evidence behind it. One of them stands on a negative trial. One stands on a real positive trial. And one of them, used alongside a common prescription, may work against it. Once you sort those out, the comparison with FemiCore gets much clearer.

What Is Uqora? The Whole Line, Sorted by Evidence

Uqora sells a system rather than a single supplement, and the company encourages stacking several products. Here is what each one contains, according to Uqora’s own product pages when I checked them in October 2026, and what the research says about the key ingredient.

Uqora product	Key ingredients	How it is used	Evidence for the key ingredient
Flush	D-mannose 2 g, potassium citrate, vitamin C	Drink mix after sex or at least every three days	Weak. A 2024 trial of 598 women found no reduction in recurrent UTI.
Flush Advanced+	D-mannose plus Pacran cranberry	Drink mix	Mixed: the cranberry half has good evidence, the d-mannose half does not
Defend	Turmeric extract, green tea extract (EGCG), vitamin D, d-mannose	2 capsules daily	Mechanism only. Uqora itself labels its biofilm claims as based on mechanism research.
Promote	L. acidophilus, L. rhamnosus, lactoferrin	1 capsule daily for 15 days a month	Some for vaginal flora; no L. crispatus
In Control	Urox (horsetail, Lindera, Crateva) plus vitamin D	2 capsules daily with food	Good for urgency. A 2018 placebo-controlled trial.
UTI Emergency Kit	Test strips, methenamine with sodium salicylate, phenazopyridine	Short-term, up to 2 days	Short-term symptom kit, not daily prevention

That table is the whole story in miniature. Uqora’s best-known product sits on its weakest evidence, and its best-supported product is aimed at urgency, not infection.

What Is FemiCore?

FemiCore is a once-daily women’s capsule built on the urinary microbiome idea. The formula combines a roughly 350 mg herbal blend, led by cranberry standardized to 30% proanthocyanidins (PACs) alongside Mimosa pudica, berberine and bearberry, with a 50 mg probiotic blend naming five Lactobacillus strains, including L. crispatus. It is sold only from its official site, made in a GMP-certified US facility, and carries a 60-day money-back guarantee processed by ClickBank.

The finished formula has not been tested in its own trial. Its case rests on its ingredients, and the two that carry the most weight, standardized cranberry and L. crispatus, are exactly the two with the strongest infection research behind them. I go through each one in the FemiCore ingredients breakdown and the product overall in my full FemiCore review.

Uqora Flush and the D-Mannose Problem

Flush is the product most women mean when they say “Uqora,” and its main active ingredient is d-mannose, a simple sugar that can bind to the hair-like fimbriae that E. coli uses to grip the bladder wall. The theory is elegant. For years the evidence was a handful of small, promising studies.

Then came the largest trial ever run on it. The MERIT trial, published in JAMA Internal Medicine in 2024, randomized 598 women with recurrent UTIs, average age 58, to daily d-mannose or placebo for six months. The share who went on to need care for a suspected UTI was 51.0% on d-mannose and 55.7% on placebo, a difference small enough to be chance. The authors’ conclusion was blunt: d-mannose should not be recommended for prophylaxis in this group.

That is a trial of daily d-mannose, while Uqora suggests Flush after sex or every few days, so the match is not perfect. But it is the best evidence that exists, and it does not support d-mannose as the backbone of a prevention plan. I went deeper into this, including the earlier positive studies and why they were weaker, in does d-mannose help bladder leaks.

The detail nobody mentions: Flush and methenamine

Flush also contains potassium citrate, which Uqora describes on its own page as a urine alkalizing agent. That matters for one specific group of readers.

Methenamine hippurate is the non-antibiotic prescription that many urologists now offer women with recurrent UTIs, after a 2022 BMJ trial (the ALTAR trial) found it held up well against daily preventive antibiotics. Methenamine only works when it breaks down into formaldehyde, and that happens in acidic urine. The FDA label for Hiprex states that its antibacterial activity is greater in acid urine and that restricting alkalinizing foods and medications is desirable.

Practical point: if your doctor has prescribed methenamine hippurate, ask your doctor or pharmacist before also drinking a product that contains potassium citrate. The two pull urine pH in opposite directions. Uqora’s own emergency kit contains methenamine, which makes this an easy combination to stumble into.

None of this applies if you are not on methenamine. But it is the kind of interaction that a stack-several-products approach makes more likely, and it is worth knowing before you build one.

Uqora In Control: Where Uqora Has the Better Evidence

Here is the concession, and it is a real one. Uqora’s In Control capsule is built on Urox, a standardized blend of horsetail, Lindera aggregata and Crateva nurvala. Urox has a 2018 randomized, double-blind, placebo-controlled trial in BMC Complementary and Alternative Medicine: 150 adults with overactive bladder symptoms, average age 63.5, of whom 59% were women. After 8 weeks, daytime urination averaged 7.69 times a day on the blend against 10.95 on placebo, and night-time trips 2.16 against 3.14.

For urgency and frequency, that is better evidence than anything FemiCore has, because FemiCore’s ingredient research is about infection. If urgency is your whole problem and you have no infections, In Control is the better-matched product of the two, and I will not pretend otherwise. The limits are the ones I list every time I write about Urox: it was a phase 2 trial, only 8 weeks long, in a mixed-sex population older than many readers, and it has not been independently replicated. In Control is the same Urox ingredient that Confitrol24 is built on, which I compared in FemiCore vs Confitrol24 and covered in detail in Urox for bladder control.

The Probiotic Difference: Which Lactobacillus Matters

Both brands sell a probiotic, but not the same bacteria, and the species is the point.

After menopause, the bacteria that most reliably protect the vagina and urinary tract are Lactobacillus crispatus. A 2026 study of 62 postmenopausal women found that those with recurrent UTIs had a marked depletion of L. crispatus compared with women who did not get infections. And the most-cited probiotic trial for recurrent UTI, a 2011 placebo-controlled trial, used L. crispatus: infections returned in 15% of the probiotic group against 27% on placebo. That overall difference did not reach statistical significance in such a small trial, and the probiotic was placed vaginally rather than swallowed, so it is promising rather than settled. But it points at one species.

Probiotic	Strains listed	Includes L. crispatus?	Dosing
Uqora Promote	L. acidophilus, L. rhamnosus, plus lactoferrin	No	1 capsule daily for 15 days a month
FemiCore	Five named Lactobacillus strains in a 50 mg blend	Yes	Inside the same daily capsule as the cranberry

Neither product has been tested in a recurrent-UTI trial of its own. But if you are choosing between them on which bacteria the research points to, FemiCore names the right one.

Key Differences at a Glance

	FemiCore	Uqora
Format	One capsule a day	Drink mix plus capsules, often stacked
Main idea	Urinary microbiome and bladder-wall defense	Flushing (d-mannose), biofilm, probiotic, or urgency, depending on product
Cranberry	Standardized to 30% PACs	Only in Flush Advanced+ (Pacran)
L. crispatus	Yes	No
Best evidence in the line	Ingredient-level, aimed at infection	In Control’s Urox trial, aimed at urgency
Weakest link	No trial of the finished formula; blend amounts not itemized	D-mannose failed a 598-woman trial
Where sold	Official site only	Uqora site and retailers such as Walmart
Guarantee	60 days	60 days
FSA/HSA	Not stated	Yes, according to Uqora

Price: One Capsule vs a System

On paper, a single Uqora product looks cheaper than FemiCore. The one-time prices on Uqora’s site when I checked were $24.99 for Flush, $29.99 each for Defend and Promote, and $34.99 for In Control, with subscription discounts and a first-order code on top. Uqora’s bundled regimens start from about $55 with subscription pricing.

FemiCore costs $79 a bottle on the 2-bottle package, $69 a bottle on the 3-bottle package with free shipping, and $49 a bottle on the 6-bottle package. That works out to roughly $2.80, $2.30 and $1.63 a day.

What you are buying	Approximate monthly cost	What it covers
FemiCore, 3-bottle package	About $69	Cranberry, probiotic and botanicals in one capsule
FemiCore, 6-bottle package	About $49	Same
Uqora Flush + Defend + Promote, one-time prices	About $85, depending on how many Flush packets you use	D-mannose, biofilm blend, probiotic without L. crispatus
Uqora In Control alone	About $35	Urgency and frequency only

Prices move with promotions on both sites, so treat these as a guide and check on the day you order. The fair comparison is not one product against one product. It is what you would actually take every month to cover the same problem.

Side Effects and Who Should Be Careful

Uqora. D-mannose is a sugar, so it is worth discussing with your doctor if you have diabetes. Flush’s potassium citrate matters if you take methenamine, and potassium itself deserves a check if you have kidney disease or take medications that raise potassium. In Control’s page warns against use with urinary retention and notes that horsetail can cause a rash in people sensitive to grasses. Horsetail is also a mild diuretic, which is an odd fit in a product meant to reduce bathroom trips.

FemiCore. The realistic issues are digestive in the first week or two. Berberine can lower blood sugar and shares liver enzyme pathways with a number of medications, so check with a pharmacist if you take diabetes medication, blood thinners or anything with a narrow dose range. Bearberry is not designed for indefinite continuous use. I cover these in FemiCore side effects.

What Neither Product Replaces

If you are past menopause and getting repeat UTIs, the single most effective step is not a supplement at all. It is low-dose vaginal estrogen, prescribed by your doctor, which the major urology guidelines recommend for exactly this. Methenamine hippurate is another evidence-based option. A supplement belongs alongside those, not instead of them, and I lay out the full evidence ranking in how to prevent recurrent UTIs naturally.

And if your leaks happen when you cough, sneeze or lift, neither brand is the answer. That is stress incontinence, a pelvic floor problem, and the best place to start is pelvic floor exercises for women over 40.

Who Should Choose Which

Choose FemiCore if you:

• Get recurrent UTIs, especially since menopause
• Want standardized cranberry and L. crispatus in a single daily capsule
• Prefer one product over building a stack
• Take methenamine and want to avoid a potassium citrate drink (still check with your pharmacist)

Choose Uqora In Control if you:

• Have urgency and frequency but no history of infections
• Want the ingredient with a placebo-controlled urgency trial
• Can take two capsules a day and have no grass or horsetail sensitivity

Be cautious about Uqora Flush if you:

• Are counting on it as your main prevention, given the 2024 d-mannose trial
• Take methenamine hippurate
• Have diabetes or kidney disease, without checking with your doctor first

Final Verdict

FemiCore: 4.3 / 5 for recurrent UTIs. Uqora In Control: 4.2 / 5 for urgency and frequency. Uqora Flush: 3.2 / 5 as a prevention backbone.

Uqora deserves credit for making women’s urinary health visible and for selling one genuinely evidence-backed product. But its famous drink mix rests on an ingredient that the best trial to date found no better than placebo, and its probiotic leaves out the species the research points to. For the woman whose problem is repeat infections, FemiCore is the more coherent choice: the two ingredients with the strongest infection research, standardized cranberry and L. crispatus, in one daily capsule, with a 60-day guarantee to test it. For urgency without infections, In Control is the better-matched Uqora product, and I would rather tell you that than sell you the wrong bottle.

Key Takeaways

• Uqora is a line, not one product. Flush, Defend, Promote and In Control rest on very different evidence.
• D-mannose failed its biggest test. The 2024 MERIT trial of 598 women found 51.0% vs 55.7% with a suspected UTI, no meaningful difference.
• In Control is Uqora’s strongest product. Its Urox blend beat placebo for urgency in a 2018 trial, but it targets urgency, not infection.
• The probiotic species matters. FemiCore names L. crispatus; Uqora Promote does not include it.
• Watch the methenamine interaction. Flush contains potassium citrate, a urine alkalizer, and methenamine works best in acidic urine.
• Vaginal estrogen comes first after menopause. Supplements support it; they do not replace it.

Frequently Asked Questions

Is FemiCore better than Uqora?

For recurrent UTIs, FemiCore is the better-matched choice because it combines cranberry standardized to 30% PACs with five named Lactobacillus strains, including L. crispatus, in one daily capsule. For urgency and frequency without infections, Uqora In Control has the stronger evidence, thanks to a 2018 placebo-controlled trial of its Urox blend.

Does Uqora actually work?

It depends on the product. Uqora Flush relies mainly on d-mannose, and a 2024 trial of 598 women found daily d-mannose did not reduce recurrent UTIs compared with placebo. Uqora In Control uses Urox, which reduced daytime and night-time urination versus placebo in a 2018 trial. Defend’s biofilm claims are based on mechanism research rather than human trials.

Can I take Uqora Flush with methenamine?

Ask your doctor or pharmacist first. Flush contains potassium citrate, which makes urine less acidic, and the FDA label for methenamine hippurate says its antibacterial activity is greater in acid urine and that restricting alkalinizing foods and medications is desirable.

Does Uqora have Lactobacillus crispatus?

Uqora Promote lists Lactobacillus acidophilus and Lactobacillus rhamnosus with lactoferrin, not Lactobacillus crispatus. FemiCore’s probiotic blend includes L. crispatus, the species most associated with a protective vaginal environment in postmenopausal women.

Which is cheaper, FemiCore or Uqora?

A single Uqora product costs about $25 to $35 one-time, but the brand encourages stacking several. FemiCore costs about $1.63 to $2.80 a day depending on the package, which is comparable to or less than a typical multi-product Uqora routine.

Can FemiCore or Uqora replace vaginal estrogen?

No. For postmenopausal women with recurrent UTIs, low-dose vaginal estrogen prescribed by a doctor has the strongest evidence and is recommended by major urology guidelines. Supplements may support it but should not replace it.

The Bottom Line

The useful way to read FemiCore vs Uqora is product by product. Uqora’s best-known drink mix is built on an ingredient that the largest trial so far found no better than placebo, and it contains a urine alkalizer that does not mix well with one of the best prescription options for recurrent UTIs. Uqora’s In Control capsule, on the other hand, is a fair choice for urgency without infections. If your problem is UTIs that keep coming back, FemiCore puts the two best-supported ingredients into one capsule, and that is the one I would try, alongside a conversation with your doctor about vaginal estrogen.

— Ellen Bennett

Further reading: FemiCore vs AZO, does cranberry work for UTIs and probiotics for bladder control.